JP2003505513A - ペンタフルオロベンゼンスルホンアミドを用いる併用療法 - Google Patents

ペンタフルオロベンゼンスルホンアミドを用いる併用療法

Info

Publication number
JP2003505513A
JP2003505513A JP2001513423A JP2001513423A JP2003505513A JP 2003505513 A JP2003505513 A JP 2003505513A JP 2001513423 A JP2001513423 A JP 2001513423A JP 2001513423 A JP2001513423 A JP 2001513423A JP 2003505513 A JP2003505513 A JP 2003505513A
Authority
JP
Japan
Prior art keywords
compound
cisplatin
substituted
alkyl
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001513423A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003505513A5 (https=
Inventor
スーザン・シュウェンドナー
ピーター・ティマーマンズ
ジャッキー・ウォーリング
Original Assignee
テュラリク インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by テュラリク インコーポレイテッド filed Critical テュラリク インコーポレイテッド
Publication of JP2003505513A publication Critical patent/JP2003505513A/ja
Publication of JP2003505513A5 publication Critical patent/JP2003505513A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Weting (AREA)
JP2001513423A 1999-07-29 2000-07-27 ペンタフルオロベンゼンスルホンアミドを用いる併用療法 Pending JP2003505513A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14643699P 1999-07-29 1999-07-29
US60/146,436 1999-07-29
PCT/US2000/020763 WO2001008693A2 (en) 1999-07-29 2000-07-27 Combination therapy using pentafluorobenzenesulfonamide and platin compound

Publications (2)

Publication Number Publication Date
JP2003505513A true JP2003505513A (ja) 2003-02-12
JP2003505513A5 JP2003505513A5 (https=) 2007-09-06

Family

ID=22517356

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001513423A Pending JP2003505513A (ja) 1999-07-29 2000-07-27 ペンタフルオロベンゼンスルホンアミドを用いる併用療法

Country Status (16)

Country Link
US (1) US6355628B1 (https=)
EP (1) EP1206256B8 (https=)
JP (1) JP2003505513A (https=)
KR (1) KR100685059B1 (https=)
CN (1) CN1181819C (https=)
AT (1) ATE294574T1 (https=)
AU (1) AU775305B2 (https=)
CA (1) CA2380078C (https=)
DE (1) DE60019937T2 (https=)
DK (1) DK1206256T3 (https=)
ES (1) ES2241639T3 (https=)
IL (2) IL147890A0 (https=)
PT (1) PT1206256E (https=)
RU (1) RU2268054C2 (https=)
WO (1) WO2001008693A2 (https=)
ZA (1) ZA200200889B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69724777T2 (de) * 1996-02-22 2004-07-15 Tularik, Inc., South San Francisco Pentafluorobenzensulfonamiden und analoge
PT939627E (pt) * 1996-07-19 2004-02-27 Tularik Inc Pentafluorobenzenossulfonamidas e analogos
ES2194547T3 (es) * 1998-09-23 2003-11-16 Tularik Inc Arilsulfonanilida-ureas.
US20050250854A1 (en) * 2000-11-03 2005-11-10 Amgen Inc. Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
WO2002039958A2 (en) 2000-11-03 2002-05-23 Tularik Inc. Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
FR2834641B1 (fr) * 2002-01-14 2005-04-22 Ct Regional De Lutte Contre Le Protection de la neurotoxicite de l'oxaliplatine par administration de calcium et de magnesium
WO2005051303A2 (en) * 2003-11-19 2005-06-09 Lixin Zhang Screening for synergistic compounds
US10238831B2 (en) 2013-09-08 2019-03-26 Qool Therapeutics, Inc. Temperature measurement and feedback for therapeutic hypothermia
CN107530187B (zh) 2015-02-23 2020-06-30 库尔诊疗公司 用于冷冻颗粒的气管内递送的系统
EP3676255B1 (en) 2017-08-29 2025-04-16 Rutgers, The State University University Of New Jersey Therapeutic indazoles
EP3684754A4 (en) * 2017-09-21 2021-06-02 Dalriada Therapeutics Inc. PENTAFLUOROPHENYL SULFONAMIDE COMPOUNDS, COMPOSITIONS AND ASSOCIATED USES

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998005315A1 (en) * 1996-07-19 1998-02-12 Tularik, Inc. Pentafluorobenzenesulfonamides and analogs

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1955207A (en) 1931-09-16 1934-04-17 Ig Farbenindustrie Ag Mothproofing agent
US2402623A (en) 1943-06-24 1946-06-25 Rohm & Haas Nu-nitroaryl haloarylsulphonamides
CH362688A (de) 1957-09-10 1962-06-30 Geigy Ag J R Verfahren zur Herstellung von neuen Arylsulfonarylamiden
GB1242057A (en) 1968-07-04 1971-08-11 Ici Ltd Derivatives of 4-hydroxytetrafluoropyridine and the use thereof as plant growth regulators
NL174644C (nl) 1970-04-13 1984-07-16 Minnesota Mining & Mfg Werkwijze ter bereiding van een herbicide verbinding; tevens werkwijze voor de bereiding van een preparaat met herbicide werking.
SE447902B (sv) * 1977-10-19 1986-12-22 Johnson Matthey Co Ltd Cis-koordinationsforening av platina och komposition innehallande foreningen
DE3623184A1 (de) 1986-07-10 1988-01-14 Kali Chemie Ag Verfahren zur herstellung von n-fluorsulfonamiden
US4883914A (en) 1987-08-17 1989-11-28 American Cyanamid Company Benzenesulfonyl carboxamide compounds useful as herbicidal agents
DE3804990A1 (de) 1988-02-18 1989-08-31 Basf Ag Herbizid wirksame, heterocyclisch substituierte sulfonamide
FR2645537B1 (fr) 1989-04-05 1994-03-04 Fabre Medicament Pierre Nouveaux sulfonamides derives d'acides benzocycliques ou benzoheterocycliques, leur preparation et leur application en therapeutique
FR2665440B1 (fr) 1990-07-31 1994-02-04 Lipha Nouveaux cycloalkylsulfonamides substitues, procedes de preparation et medicaments les contenant.
US5189211A (en) 1990-08-01 1993-02-23 Taisho Pharmaceutical Co., Ltd. Sulfonamide derivatives
EP0472053B1 (en) 1990-08-20 1998-06-17 Eisai Co., Ltd. Sulfonamide derivatives
RU2088288C1 (ru) * 1993-07-29 1997-08-27 Московский областной научно-исследовательский клинический институт Способ лечения больных местнораспространенными формами рака
RU2098096C1 (ru) * 1993-10-11 1997-12-10 Московский научно-исследовательский онкологический институт им.П.А.Герцена Средства, подавляющие рост раковых клеток
WO1996040629A1 (en) 1995-06-07 1996-12-19 Sugen, Inc. Tyrphostin-like compounds for the treatment of cell proliferative disorders or cell differentiation disorders
DE69724777T2 (de) 1996-02-22 2004-07-15 Tularik, Inc., South San Francisco Pentafluorobenzensulfonamiden und analoge
CZ298022B6 (cs) * 1996-10-15 2007-05-30 G. D. Searle & Co. Použití inhibitoru cyklooxygenázy-2 pro výrobu léciva pro lécení a prevenci neoplazie
JP2001505564A (ja) * 1996-11-19 2001-04-24 ジー．ディー．サール アンド カンパニー 抗血管新生剤としてのシクロオキシゲナーゼ―２阻害剤の使用方法
US5773236A (en) 1997-04-25 1998-06-30 Molecule Probes, Inc. Assay for glutathiane transferase using polyhaloaryl-substituted reporter molecules
ATE248845T1 (de) * 1998-06-25 2003-09-15 Tularik Inc Arylsulfonanilid-phosphate
ES2194547T3 (es) * 1998-09-23 2003-11-16 Tularik Inc Arilsulfonanilida-ureas.
AU2190700A (en) * 1998-12-17 2000-07-03 Tularik Inc. Tubulin-binding agents
CO5170498A1 (es) * 1999-05-28 2002-06-27 Abbott Lab Biaril sulfonamidas son utiles como inhibidores de proliferacion celular

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998005315A1 (en) * 1996-07-19 1998-02-12 Tularik, Inc. Pentafluorobenzenesulfonamides and analogs

Also Published As

Publication number Publication date
CA2380078C (en) 2008-05-06
EP1206256B1 (en) 2005-05-04
EP1206256B8 (en) 2005-06-29
WO2001008693A3 (en) 2001-05-25
ZA200200889B (en) 2003-03-26
US6355628B1 (en) 2002-03-12
KR20020050225A (ko) 2002-06-26
DK1206256T3 (da) 2005-08-15
ES2241639T3 (es) 2005-11-01
CA2380078A1 (en) 2001-02-08
CN1181819C (zh) 2004-12-29
AU6615200A (en) 2001-02-19
PT1206256E (pt) 2005-09-30
EP1206256A2 (en) 2002-05-22
AU775305B2 (en) 2004-07-29
RU2002105374A (ru) 2004-01-10
KR100685059B1 (ko) 2007-02-22
CN1367690A (zh) 2002-09-04
IL147890A (en) 2007-07-04
WO2001008693A2 (en) 2001-02-08
RU2268054C2 (ru) 2006-01-20
DE60019937T2 (de) 2006-05-04
IL147890A0 (en) 2002-08-14
ATE294574T1 (de) 2005-05-15
DE60019937D1 (de) 2005-06-09

Similar Documents

Publication Publication Date Title
DE69822659T2 (de) Formulierungen und Verfahren zur Verminderung der Toxizität von Anti-Neoplastischen Mitteln
KR101716804B1 (ko) 항종양 알칼로이드를 이용한 병용요법
BG107843A (bg) Ефективно антитуморно лечение
JP2003505513A (ja) ペンタフルオロベンゼンスルホンアミドを用いる併用療法
CA2836385A1 (en) Method for treatment of advanced solid tumors
JP5514123B2 (ja) 卵巣癌を治療するための、パクリタキセルを含む配合剤
EP1691809A1 (en) Combination therapy comprising the use of et-743 and paclitaxel for treating cancer
US6822001B2 (en) Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
JP2023509191A (ja) 癌を治療するための組み合わせ療法
PT1757283E (pt) Potenciador do efeito antitumoral, agente antitumoral e método para a terapia do cancro
RU2279277C2 (ru) Лечение разделенными дозами агентов с сосудоразрушающей активностью
CN121419775A (zh) 用于预防或治疗肺纤维化的培西达替尼和尼达尼布的联合疗法
TW200846013A (en) Cytidine derivative-containing antitumor agent for continuous intravenous administration
JPH0288524A (ja) 抗腫瘍剤
CN102245175A (zh) 含有ave8062 和多西紫杉醇的抗肿瘤组合
MXPA06005359A (en) Combination therapy comprising the use of et-743 and paclitaxel for treating cancer
HK1202419B (en) Combination therapy with a mitotic inhibitor

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070712

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070712

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20071114

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20071114

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20071114

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101116

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110719